Rational thresholding of circulating tumor DNA concentration for ...

Intensive ctDNA quantification improves metastatic breast cancer surveillance and enables individualized risk-based scheduling of clinical care.

28P Rational thresholding of circulating tumor DNA copy number for ...

Circulating tumor DNA (ctDNA) is promising as tumor-specific marker for progression surveillance in metastatic cancer. Our aim was to investigate the ...

(PDF) Rational thresholding of circulating tumor DNA concentration ...

Password Forgot password? ... Welcome back! Please log in. ... Password Forgot password? Keep me logged ...

ctDNA Tumor Fraction Matters When Interpreting Liquid Biopsy Test ...

Liquid Biopsies Increasingly Common · Biomarker Threshold Lowered from 10% to 1% · Consider Tissue Biopsy at Metastatic Diagnosis and Liquid ...

Prognostic value of plasma circulating tumor DNA fraction across ...

Genomic analysis of circulating tumor DNA (ctDNA) is increasingly incorporated into the clinical management of patients with advanced cancer ...

Circulating tumor DNA-based stratification strategy for ... - Cell Press

Moreover, we demonstrated potential applications for the dynamic monitoring of ctDNA. Overall, we proposed a potential therapeutic algorithm ...

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA

Liquid biopsy using blood components to assess circulating tumor DNA (ctDNA) is rapidly becoming a new standard-of-care technology in many tumor types, ...

Monitoring and adapting cancer treatment using circulating tumor ...

Quantitative and digital polymerase chain reactions (PCRs) were the first ctDNA detection approaches for small numbers of targets and remain ...

Circulating Tumor DNA Analyses as Markers of Recurrence Risk ...

Kaplan-Meier estimates of RFI at 3 years for patients with positive ctDNA findings were 47% (95% CI, 24%-68%) and for those with ctDNA-negative ...

Circulating Tumor DNA - an overview | ScienceDirect Topics

Circulating tumor DNA holds substantial promise as an early detection biomarker, particularly for cancers that do not have currently accepted screening ...

Circulating Tumor DNA and Survival in Metastatic Breast Cancer

The minimally invasive nature of liquid biopsy allows for more frequent sample collection, offering a comprehensive view of an individual's ...

Circulating Tumor DNA Analysis in Patients With Cancer: American ...

Purpose Clinical use of analytical tests to assess genomic variants in circulating tumor DNA (ctDNA) is increasing. This joint review from ASCO and the College ...

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer ...

While a trend toward the DNA concentration in the blood of cancer patients being much higher than in the blood of healthy controls and nonmalignant patients is ...

Circulating tumor cells and circulating tumor DNA for precision ...

Currently, this is considered a major reason for treatment failures in cancer care. Recent technological advances in the detection and characterization of ...

Detection of Circulating Tumor DNA in Human Blood via DNA ...

The levels of circulating tumor DNA (ctDNA) in the peripheral blood have been associated with tumor burden and malignant progression.

Rational design of on-chip gold plasmonic nanoparticles towards ...

We have thoroughly characterized the impact of nanoparticle geometry on the sensitivity to circulating tumor DNA, with immediate implications ...

Liquid biopsies to monitor and direct cancer treatment in colorectal ...

Circulating tumour DNA (ctDNA), circulating tumour cells (CTCs) and exosomes are the most common tumour-related biomarkers assessed on liquid ...

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis

There is no unified standard for detecting ctDNA as it exists in a low concentration in blood. As there is no defined approach, false positives ...

Circulating Tumor DNA in HER2-Amplified Breast Cancer - OUCI

Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer. G.A. Martens, J. Demol, F. Dedeurwaerdere ...

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA

Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer. G.A. Martens, J. Demol, F. Dedeurwaerdere ...